Osterman MT, Lichtenstein GR: Chapter 116: Ulcerative Colitis Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 10th Edition : 2023-61,2016.
Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Osterman MT, Beukelman T, Margolis D, Curtis JR, Lewis JD: Risk of non-melanoma skin cancer recurrence with the use of immunomodulators and biologic agents in autoimmune disease JAMA Dermatology 152 (2): 164-72,2016.
Roblin X, Osterman MT, Glover S, Navaneethan U, Popa MA, Wyant T, James A, Lasch K, Rosario M: The relationship between vedolizumab drug concentrations at or before week 6 and remission at week 14 in ulcerative colitis patients from GEMINI 1 Journal of Crohns and Colitis : 2016.
Scott FI, Osterman MT: Therapeutic drug monitoring of biologic agents Biologics in Inflammatory Bowel Disease : 2016.
Osterman MT, Roblin X, Glover S, Navaneethan U, Popa MA, Wyant T, James A, Lasch K, Rosario M: The relationship between vedolizumab drug concentrations at or before week 6 and remission at week 14 in ulcerative colitis patients from GEMINI 1 Gastroenterology : 2016.
Osterman MT, Lichtenstein GR: Medical treatment of perianal Crohn’s fistulae Pediatric Inflammatory Bowel Disease: Third Edition : 2016.
Chachu KA, Osterman MT: How to diagnose and treat IBD mimics in the refractory IBD patient who does not have IBD Inflammatory Bowel Diseases : 2016.
Zhang J, Xie F, Yun H, Chen L, Muntner P, Levitan EB, Safford MM, Kent ST, Osterman MT, Lewis JD, Saag K, Singh JA, Curtis JR: Comparative effects of biologics on coronary cardiovascular risk among older patients with rheumatoid arthritis Annals of the Rheumatic Diseases : 2016.
Mamtani R, Clark AS, Scott FI, Brensinger CM, Boursi B, Chen L, Xie F, Yun H, Osterman MT, Curtis JR, Lewis JD: Association between breast cancer recurrence with immunosuppression in rheumatoid arthritis and inflammatory bowel disease: a cohort study Arhritis and Rheumatology : 2016.
Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI: Predictors and Clinical Impact of Indeterminate QuantiFERON-TB Gold Testing in Inflammatory Bowel Disease Pharmacoepidemiology and Drug Safety : 2016.
View all publications